News Project seeks to shape digital health reimbursement in APAC APACMed and Eversana join forces to draw up coverage frameworks applicable to APAC countries.
News FDA rejects AbbVie’s continuous Parkinson’s therapy Delay could narrow the gap between AbbVie's product and a rival system from Mitsubishi Tanabe.
News Rapid UTI tests could cut antibiotic resistance, says NICE Rapid urine tests could help NHS ensure that antibiotics are used appropriately.
News Sobi plans filings for gout drug after phase 3 readout SEL-212 will compete with Horizon's fast-growing Krystexxa if approved by the FDA.
News Illumina says Icahn’s board candidates “do not add value” Icahn's board picks "will damage Illumina’s core business," says the gene sequencing company.
News FDA sets new decision date for Ipsen’s FOP therapy US agency sets 23rd August deadline for palovarotene review as Ipsen files more clinical data.
News Third Rock in $2bn drug-hunting pact with China's Funnel New Chinese biotech Funnel has signed a $2bn-plus partnership with Third Rock Ventures, focused on using its AI platform to discover novel biologics.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
